The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dorval Allison since 2020.
This trader's CIK number is 1625110.
At the time of last reporting, Dorval Allison was the Director of Puma Biotechnology, Inc.. (stock ticker symbol PBYI).
Also see all insider trading activities at Puma Biotechnology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PBYI | 0 | $0 | 11,610 | $39,474 | 0 | $0 |
| 2024 | PBYI | 0 | $0 | 11,000 | $37,092 | 0 | $0 |
| 2023 | PBYI | 0 | $0 | 10,000 | $34,500 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | VERV | 0 | $0 | 3,350 | $13,902 | 11,250 | $0 |
| 2024 | VERV | 0 | $0 | 555 | $3,130 | 1,875 | $0 |
| 2023 | VERV | 0 | $0 | 554 | $6,343 | 1,875 | $0 |
| 2022 | VERV | 0 | $0 | 554 | $12,243 | 1,875 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | VYGR | 0 | $0 | 6,128 | $49,414 | 0 | $0 |
| 2020 | VYGR | 0 | $0 | 3,128 | $41,790 | 0 | $0 |
1. Puma Biotechnology, Inc. (PBYI)
2. Verve Therapeutics, Inc. (VERV)
3. Voyager Therapeutics, Inc. (VYGR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-13 | PBYI | Sale | 11,610 | 3.40 | 39,474 |
| 2024-06-13 | PBYI | Sale | 11,000 | 3.37 | 37,092 |
| 2023-06-13 | PBYI | Sale | 10,000 | 3.45 | 34,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-01 | VERV | Option Ex | 11,250 | .00 | 0 |
| 2025-04-02 | VERV | Sale | 3,350 | 4.15 | 13,902 |
| 2024-11-29 | VERV | Option Ex | 1,875 | .00 | 0 |
| 2024-12-02 | VERV | Sale | 555 | 5.64 | 3,130 |
| 2023-11-29 | VERV | Sale | 554 | 11.45 | 6,343 |
| 2023-11-29 | VERV | Option Ex | 1,875 | .00 | 0 |
| 2022-11-29 | VERV | Option Ex | 1,875 | .00 | 0 |
| 2022-11-29 | VERV | Sale | 554 | 22.10 | 12,243 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-11 | VYGR | Sale | 3,186 | 7.55 | 24,054 |
| 2021-01-12 | VYGR | Sale | 2,942 | 8.62 | 25,360 |
| 2020-01-21 | VYGR | Sale | 3,128 | 13.36 | 41,790 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dorval Allison (Director of Puma Biotechnology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.